Cisplatin treatment increases stemness through upregulation of hypoxia‐inducible factors by interleukin‐6 in non‐small cell lung cancer

Cisplatin‐resistant A549 and H157 (A549CisR and H157CisR) non‐small cell lung cancer cells show increased stemness of cancer stem cells (CSCs) compared to their parental cells. We investigated whether interleukin‐6 (IL‐6) signaling contributes to this increased stemness in cisplatin‐resistant cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fuquan, Duan, Shanzhou, Tsai, Ying, Keng, Peter C., Chen, Yongbing, Lee, Soo Ok, Chen, Yuhchyau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968604/
https://www.ncbi.nlm.nih.gov/pubmed/27009878
http://dx.doi.org/10.1111/cas.12937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968604/
https://www.ncbi.nlm.nih.gov/pubmed/27009878
http://dx.doi.org/10.1111/cas.12937

Ejemplares similares